Literature DB >> 33382973

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.

Michael Heming1, Xiaolin Li1, Saskia Räuber1, Anne K Mausberg2, Anna-Lena Börsch1, Maike Hartlehnert1, Arpita Singhal3, I-Na Lu1, Michael Fleischer2, Fabian Szepanowski2, Oliver Witzke4, Thorsten Brenner5, Ulf Dittmer6, Nir Yosef7, Christoph Kleinschnitz2, Heinz Wiendl1, Mark Stettner8, Gerd Meyer Zu Hörste9.   

Abstract

Patients suffering from Coronavirus disease 2019 (COVID-19) can develop neurological sequelae, such as headache and neuroinflammatory or cerebrovascular disease. These conditions-termed here as Neuro-COVID-are more frequent in patients with severe COVID-19. To understand the etiology of these neurological sequelae, we utilized single-cell sequencing and examined the immune cell profiles from the cerebrospinal fluid (CSF) of Neuro-COVID patients compared with patients with non-inflammatory and autoimmune neurological diseases or with viral encephalitis. The CSF of Neuro-COVID patients exhibited an expansion of dedifferentiated monocytes and of exhausted CD4+ T cells. Neuro-COVID CSF leukocytes featured an enriched interferon signature; however, this was less pronounced than in viral encephalitis. Repertoire analysis revealed broad clonal T cell expansion and curtailed interferon response in severe compared with mild Neuro-COVID patients. Collectively, our findings document the CSF immune compartment in Neuro-COVID patients and suggest compromised antiviral responses in this setting.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Neuro-COVID; SARS-CoV-2; T cell exhaustion; cerebrospinal fluid; interferon-stimulated genes; neurological manifestation; single-cell RNA sequencing; transcriptomics

Year:  2020        PMID: 33382973     DOI: 10.1016/j.immuni.2020.12.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

1.  Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges.

Authors:  David Schafflick; Jolien Wolbert; Michael Heming; Christian Thomas; Maike Hartlehnert; Anna-Lena Börsch; Alessio Ricci; Sandra Martín-Salamanca; Xiaolin Li; I-Na Lu; Mathias Pawlak; Jens Minnerup; Jan-Kolja Strecker; Thomas Seidenbecher; Sven G Meuth; Andres Hidalgo; Arthur Liesz; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  Nat Neurosci       Date:  2021-07-12       Impact factor: 24.884

2.  Data Sharing and Reuse: A Method by the AIRR Community.

Authors:  Brian D Corrie; Scott Christley; Christian E Busse; Lindsay G Cowell; Kira C M Neller; Florian Rubelt; Nicholas Schwab
Journal:  Methods Mol Biol       Date:  2022

Review 3.  What SARS-CoV-2 does to our brains.

Authors:  Tom Aschman; Ronja Mothes; Frank L Heppner; Helena Radbruch
Journal:  Immunity       Date:  2022-06-20       Impact factor: 43.474

Review 4.  SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Eduardo Agüera; Javier Caballero-Villarraso; Alberto Galván; Isaac Túnez
Journal:  J Neurol       Date:  2022-07-05       Impact factor: 6.682

5.  ACTIVA: realistic single-cell RNA-seq generation with automatic cell-type identification using introspective variational autoencoders.

Authors:  A Ali Heydari; Oscar A Davalos; Lihong Zhao; Katrina K Hoyer; Suzanne S Sindi
Journal:  Bioinformatics       Date:  2022-02-18       Impact factor: 6.931

Review 6.  Single-cell immunology of SARS-CoV-2 infection.

Authors:  Yuan Tian; Lindsay N Carpp; Helen E R Miller; Michael Zager; Evan W Newell; Raphael Gottardo
Journal:  Nat Biotechnol       Date:  2021-12-20       Impact factor: 68.164

Review 7.  Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies.

Authors:  Johann Sellner; Paulus S Rommer
Journal:  Vaccines (Basel)       Date:  2021-01-28

8.  Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.

Authors:  Yadi Zhou; Jielin Xu; Yuan Hou; James B Leverenz; Asha Kallianpur; Reena Mehra; Yunlong Liu; Haiyuan Yu; Andrew A Pieper; Lara Jehi; Feixiong Cheng
Journal:  bioRxiv       Date:  2021-03-22

Review 9.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

10.  Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.

Authors:  Yadi Zhou; Jielin Xu; Yuan Hou; James B Leverenz; Asha Kallianpur; Reena Mehra; Yunlong Liu; Haiyuan Yu; Andrew A Pieper; Lara Jehi; Feixiong Cheng
Journal:  Alzheimers Res Ther       Date:  2021-06-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.